Pantoprazole Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 40mg
Reference Brands: Protonix IV (USA), Pantoloc (EU), Pantocid (India)
Category:
Gastrointestinal Drugs
Pantoprazole injection is used to treat certain conditions in which there is too much acid in the stomach. It is used for short-term treatment (7 to 10 days) of gastroesophageal reflux disease (GERD) with a history of erosive esophagitis.
Pantoprazole Injection is available in Injection
and strengths such as 40mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pantoprazole Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pantoprazole Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Pantoprazole sodium sesquihydrate is a proton pump inhibitor (PPI) widely used for the treatment and management of acid-related gastrointestinal disorders. It works by irreversibly inhibiting the H⁺/K⁺ ATPase enzyme system (proton pump) in the gastric parietal cells, thereby effectively reducing gastric acid secretion. This mechanism provides relief from acid-related symptoms and promotes healing of damaged gastrointestinal tissues.
Pantoprazole is approved for the treatment and maintenance of erosive esophagitis associated with gastroesophageal reflux disease (GERD), as well as for pathological hypersecretory conditions such as Zollinger–Ellison syndrome. It is commonly used in both inpatient and outpatient settings due to its well-established safety profile and availability in multiple formulations suitable for both adult and pediatric patients.
In addition to its approved indications, pantoprazole is also widely prescribed off-label in combination therapy for the eradication of Helicobacter pylori infection, prevention of NSAID-induced gastric ulcers, and as prophylaxis against stress-related mucosal damage in critically ill patients. Its efficacy, tolerability, and versatility make it a cornerstone therapy in the management of acid-related disorders.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing